Literature DB >> 33750973

The nature of genetic and environmental susceptibility to multiple sclerosis.

Douglas S Goodin1, Pouya Khankhanian2, Pierre-Antoine Gourraud1,3,4, Nicolas Vince3,4.   

Abstract

OBJECTIVE: To understand the nature of genetic and environmental susceptibility to multiple sclerosis (MS) and, by extension, susceptibility to other complex genetic diseases.
BACKGROUND: Certain basic epidemiological parameters of MS (e.g., population-prevalence of MS, recurrence-risks for MS in siblings and twins, proportion of women among MS patients, and the time-dependent changes in the sex-ratio) are well-established. In addition, more than 233 genetic-loci have now been identified as being unequivocally MS-associated, including 32 loci within the major histocompatibility complex (MHC), and one locus on the X chromosome. Despite this recent explosion in genetic associations, however, the association of MS with the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 (H+) haplotype has been known for decades. DESIGN/
METHODS: We define the "genetically-susceptible" subset (G) to include everyone with any non-zero life-time chance of developing MS. Individuals who have no chance of developing MS, regardless of their environmental experiences, belong to the mutually exclusive "non-susceptible" subset (G-). Using these well-established epidemiological parameters, we analyze, mathematically, the implications that these observations have regarding the genetic-susceptibility to MS. In addition, we use the sex-ratio change (observed over a 35-year interval in Canada), to derive the relationship between MS-probability and an increasing likelihood of a sufficient environmental exposure.
RESULTS: We demonstrate that genetic-susceptibitly is confined to less than 7.3% of populations throughout Europe and North America. Consequently, more than 92.7% of individuals in these populations have no chance whatsoever of developing MS, regardless of their environmental experiences. Even among carriers of the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 haplotype, far fewer than 32% can possibly be members the (G) subset. Also, despite the current preponderance of women among MS patients, women are less likely to be in the susceptible (G) subset and have a higher environmental threshold for developing MS compared to men. Nevertheless, the penetrance of MS in susceptible women is considerably greater than it is in men. Moreover, the response-curves for MS-probability in susceptible individuals increases with an increasing likelihood of a sufficient environmental exposure, especially among women. However, these environmental response-curves plateau at under 50% for women and at a significantly lower level for men.
CONCLUSIONS: The pathogenesis of MS requires both a genetic predisposition and a suitable environmental exposure. Nevertheless, genetic-susceptibility is rare in the population (< 7.3%) and requires specific combinations of non-additive genetic risk-factors. For example, only a minority of carriers of the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 haplotype are even in the (G) subset and, thus, genetic-susceptibility to MS in these carriers must result from the combined effect this haplotype together with the effects of certain other (as yet, unidentified) genetic factors. By itself, this haplotype poses no MS-risk. By contrast, a sufficient environmental exposure (however many events are involved, whenever these events need to act, and whatever these events might be) is common, currently occurring in, at least, 76% of susceptible individuals. In addition, the fact that environmental response-curves plateau well below 50% (especially in men), indicates that disease pathogenesis is partly stochastic. By extension, other diseases, for which monozygotic-twin recurrence-risks greatly exceed the disease-prevalence (e.g., rheumatoid arthritis, diabetes, and celiac disease), must have a similar genetic basis.

Entities:  

Year:  2021        PMID: 33750973      PMCID: PMC7984655          DOI: 10.1371/journal.pone.0246157

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  68 in total

Review 1.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

2.  A meta-analysis of whole genome linkage screens in multiple sclerosis.

Authors: 
Journal:  J Neuroimmunol       Date:  2003-10       Impact factor: 3.478

3.  INCIDENCE OF INFARCTS OF THE BRAIN IN HEART DISEASES.

Authors:  A VOST; D A WOLOCHOW; D A HOWELL
Journal:  J Pathol Bacteriol       Date:  1964-10

4.  Genomewide study of multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Carl Anderson; A Dessa Sadovnick; George C Ebers
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

Review 5.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

6.  Age at onset in multiple sclerosis.

Authors:  M Liguori; M G Marrosu; M Pugliatti; F Giuliani; F De Robertis; E Cocco; G B Zimatore; P Livrea; M Trojano
Journal:  Neurol Sci       Date:  2000       Impact factor: 3.307

7.  The British Isles survey of multiple sclerosis in twins.

Authors:  C J Mumford; N W Wood; H Kellar-Wood; J W Thorpe; D H Miller; D A Compston
Journal:  Neurology       Date:  1994-01       Impact factor: 9.910

8.  Multiple sclerosis in stepsiblings: recurrence risk and ascertainment.

Authors:  D A Dyment; I M L Yee; G C Ebers; A D Sadovnick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

9.  HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.

Authors:  Michael J Chao; Martin C N M Barnardo; Matthew R Lincoln; Sreeram V Ramagopalan; Blanca M Herrera; David A Dyment; Alexandre Montpetit; A Dessa Sadovnick; Julian C Knight; George C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

10.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

Authors:  Ashley H Beecham; Nikolaos A Patsopoulos; Dionysia K Xifara; Mary F Davis; Anu Kemppinen; Chris Cotsapas; Tejas S Shah; Chris Spencer; David Booth; An Goris; Annette Oturai; Janna Saarela; Bertrand Fontaine; Bernhard Hemmer; Claes Martin; Frauke Zipp; Sandra D'Alfonso; Filippo Martinelli-Boneschi; Bruce Taylor; Hanne F Harbo; Ingrid Kockum; Jan Hillert; Tomas Olsson; Maria Ban; Jorge R Oksenberg; Rogier Hintzen; Lisa F Barcellos; Cristina Agliardi; Lars Alfredsson; Mehdi Alizadeh; Carl Anderson; Robert Andrews; Helle Bach Søndergaard; Amie Baker; Gavin Band; Sergio E Baranzini; Nadia Barizzone; Jeffrey Barrett; Céline Bellenguez; Laura Bergamaschi; Luisa Bernardinelli; Achim Berthele; Viola Biberacher; Thomas M C Binder; Hannah Blackburn; Izaura L Bomfim; Paola Brambilla; Simon Broadley; Bruno Brochet; Lou Brundin; Dorothea Buck; Helmut Butzkueven; Stacy J Caillier; William Camu; Wassila Carpentier; Paola Cavalla; Elisabeth G Celius; Irène Coman; Giancarlo Comi; Lucia Corrado; Leentje Cosemans; Isabelle Cournu-Rebeix; Bruce A C Cree; Daniele Cusi; Vincent Damotte; Gilles Defer; Silvia R Delgado; Panos Deloukas; Alessia di Sapio; Alexander T Dilthey; Peter Donnelly; Bénédicte Dubois; Martin Duddy; Sarah Edkins; Irina Elovaara; Federica Esposito; Nikos Evangelou; Barnaby Fiddes; Judith Field; Andre Franke; Colin Freeman; Irene Y Frohlich; Daniela Galimberti; Christian Gieger; Pierre-Antoine Gourraud; Christiane Graetz; Andrew Graham; Verena Grummel; Clara Guaschino; Athena Hadjixenofontos; Hakon Hakonarson; Christopher Halfpenny; Gillian Hall; Per Hall; Anders Hamsten; James Harley; Timothy Harrower; Clive Hawkins; Garrett Hellenthal; Charles Hillier; Jeremy Hobart; Muni Hoshi; Sarah E Hunt; Maja Jagodic; Ilijas Jelčić; Angela Jochim; Brian Kendall; Allan Kermode; Trevor Kilpatrick; Keijo Koivisto; Ioanna Konidari; Thomas Korn; Helena Kronsbein; Cordelia Langford; Malin Larsson; Mark Lathrop; Christine Lebrun-Frenay; Jeannette Lechner-Scott; Michelle H Lee; Maurizio A Leone; Virpi Leppä; Giuseppe Liberatore; Benedicte A Lie; Christina M Lill; Magdalena Lindén; Jenny Link; Felix Luessi; Jan Lycke; Fabio Macciardi; Satu Männistö; Clara P Manrique; Roland Martin; Vittorio Martinelli; Deborah Mason; Gordon Mazibrada; Cristin McCabe; Inger-Lise Mero; Julia Mescheriakova; Loukas Moutsianas; Kjell-Morten Myhr; Guy Nagels; Richard Nicholas; Petra Nilsson; Fredrik Piehl; Matti Pirinen; Siân E Price; Hong Quach; Mauri Reunanen; Wim Robberecht; Neil P Robertson; Mariaemma Rodegher; David Rog; Marco Salvetti; Nathalie C Schnetz-Boutaud; Finn Sellebjerg; Rebecca C Selter; Catherine Schaefer; Sandip Shaunak; Ling Shen; Simon Shields; Volker Siffrin; Mark Slee; Per Soelberg Sorensen; Melissa Sorosina; Mireia Sospedra; Anne Spurkland; Amy Strange; Emilie Sundqvist; Vincent Thijs; John Thorpe; Anna Ticca; Pentti Tienari; Cornelia van Duijn; Elizabeth M Visser; Steve Vucic; Helga Westerlind; James S Wiley; Alastair Wilkins; James F Wilson; Juliane Winkelmann; John Zajicek; Eva Zindler; Jonathan L Haines; Margaret A Pericak-Vance; Adrian J Ivinson; Graeme Stewart; David Hafler; Stephen L Hauser; Alastair Compston; Gil McVean; Philip De Jager; Stephen J Sawcer; Jacob L McCauley
Journal:  Nat Genet       Date:  2013-09-29       Impact factor: 38.330

View more
  6 in total

Review 1.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

Review 2.  Predicting Multiple Sclerosis: Challenges and Opportunities.

Authors:  Luke Hone; Gavin Giovannoni; Ruth Dobson; Benjamin Meir Jacobs
Journal:  Front Neurol       Date:  2022-02-08       Impact factor: 4.086

3.  Exosomes with FOXP3 from gene-modified dendritic cells ameliorate the development of EAE by regulating the balance of Th/Treg.

Authors:  Zhen Jia; Jia Liu; Bin Li; Le Yi; Yanmin Wu; Junna Xing; Liang Wang; Jinli Wang; Li Guo
Journal:  Int J Med Sci       Date:  2022-07-11       Impact factor: 3.642

4.  Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients-The Example of Croatia.

Authors:  Ana Jerković; Sanda Pavelin; Joško Šoda; Igor Vujović; Maja Rogić Vidaković
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

5.  Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.

Authors:  Julia Horjus; Tineke van Mourik-Banda; Marco A P Heerings; Marina Hakobjan; Ward De Witte; Dorothea J Heersema; Anne J Jansen; Eva M M Strijbis; Brigit A de Jong; Astrid E J Slettenaar; Esther M P E Zeinstra; Erwin L J Hoogervorst; Barbara Franke; Wiebe Kruijer; Peter J Jongen; Leo J Visser; Geert Poelmans
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

6.  Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions.

Authors:  D S Goodin; P Khankhanian; P A Gourraud; N Vince
Journal:  BMC Med Genomics       Date:  2021-07-10       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.